Benzalazine
Benzalazine is a 5-azo derivative of 5-Aminosalicylic Acid (HY-15027) that can be used for the research of ulcerative colitis and Crohn's disease of the large intestine. The benzalazine metabolite 5-ASA and the 5-ASA metabolite acetyl-5-aminosalicylic acid are excreted mainly with the faeces[1].
Product Specifications
CAS Number
[588-68-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H317, H319, H332, H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Inflammation/Immunology
Purity
98.82
Smiles
C1(/C=N/N=C/C2=CC=CC=C2)=CC=CC=C1
Molecular Formula
C14H12N2
Molecular Weight
208.26
Precautions
H302, H315, H317, H319, H332, H335
References & Citations
[1]Herzog R, et, al. Pharmacokinetic studies of benzalazine. Arzneimittelforschung. 1994 Dec;44 (12) :1381-3.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items